Fluocinolone Acetonide (0.19 mcg/day) Intravitreal Implant and Improved Treatment Burden for Patients with Diabetic Macular Edema (DME)

Byun Matthew; Riemann Christopher D.; Osher James; Patel Yogin

首页> 外文期刊>Investigative ophthalmology & visual science >Fluocinolone Acetonide (0.19 mcg/day) Intravitreal Implant and Improved Treatment Burden for Patients with Diabetic Macular Edema (DME)

【24h】

Fluocinolone Acetonide (0.19 mcg/day) Intravitreal Implant and Improved Treatment Burden for Patients with Diabetic Macular Edema (DME)

机译：氟尿酮醋酸盐（0.19mcg /天）玻璃体植入物植入物和糖尿病患者的治疗负担（DME）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Investigative ophthalmology & visual science》 |2018年第9期|共1页
作者
Byun Matthew; Riemann Christopher D.; Osher James; Patel Yogin;
展开▼
作者单位

Univ Cincinnati Ophthalmol Cincinnati OH USA;

Univ Cincinnati Ophthalmol Cincinnati OH USA;

Univ Cincinnati Ophthalmol Cincinnati OH USA;

Univ Cincinnati Ophthalmol Cincinnati OH USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. Fluocinolone Acetonide (0.19 mcg/day) Intravitreal Implant and Improved Treatment Burden for Patients with Diabetic Macular Edema (DME) [J] . Byun Matthew, Riemann Christopher D., Osher James, Investigative ophthalmology & visual science . 2018,第9期

机译：氟尿酮醋酸盐（0.19mcg /天）玻璃体植入物植入物和糖尿病患者的治疗负担（DME）
2. Fluocinolone acetonide 0.19 mg intravitreal implant improves foveal thickness and reduces treatment burden for up to 1 year in eyes with persistent diabetic macular edema [J] . Joseph M Coney International Medical Case Reports Journal . 2019,第33期

机译：氟西诺酮0.19 mg玻璃体内植入物可改善患有持续性糖尿病性黄斑水肿的眼睛的中央凹厚度并减轻治疗负担长达1年
3. Three-year results from the Retro-IDEAL study: Real-world data from diabetic macular edema (DME) patients treated with ILUVIEN ? (0.19?mg fluocinolone acetonide implant) [J] . European journal of ophthalmology . 2020,第2期

机译：复古理想研究的三年成果：糖尿病黄斑水肿（DME）患者的真实世界数据患者治疗伊鲁维恩患者？（0.19？mg氟氨基甘油酮丙酮烯植入物）
4. Pharmacokinetic Modeling to Improve the Design of Intravitreal Corticosteroid Implants for Treating Macular Edema [C] . Susan S. Lee, David Z. DArgenio, Rex A. Moats, Controlled Release Society Annual Meeting and Exposition . 2007

机译：药物动力学模型可改善玻璃体皮质类固醇植入物治疗黄斑水肿的设计
5. Prediction of visual acuity loss and indications for laser treatment in patients with diabetic macular edema using the Heidelberg Retina Tomograph. [D] . O'Neal, Dennis A. 2007

机译：使用海德堡视网膜断层扫描仪预测糖尿病性黄斑水肿患者的视力下降和激光治疗的适应症。
6. Fluocinolone acetonide 0.19 mg intravitreal implant improves foveal thickness and reduces treatment burden for up to 1 year in eyes with persistent diabetic macular edema [O] . Joseph M Coney 2019

机译：氟西诺酮0.19 mg玻璃体内植入物可改善患有持续性糖尿病性黄斑水肿的眼睛的中央凹厚度并减轻治疗负担长达1年
7. Fluocinolone acetonide (0.19 mg) intravitreal implant reduces treatment burden and improves practice resource utilisation for patients with diabetic macular oedema [O] . Matthew Byun, James Osher, Christopher D Riemann 2020

机译：氟尿酮醋酸盐（0.19mg）玻璃体内植入物可降低治疗负担，提高患有糖尿病黄斑水肿患者的实践资源利用率

Fluocinolone Acetonide (0.19 mcg/day) Intravitreal Implant and Improved Treatment Burden for Patients with Diabetic Macular Edema (DME)

著录项

相似文献

相关主题

期刊订阅